Tag: smear test

May 06, 2013 “Intelligence: Late Breaking Lab News”

Much is happening in the anatomic pathology market in the Pacific Northwest. PAML, LLC (Spokane, Washington), and CellNetix (Seattle, Washington) finally executed the agreement whereby PAML made an equity investment in CellNetix. Now, the two lab companies will collaborate on developing a reference and esoteric anatomic pathology testing service with national ambitions. Within days of

View Article

Using Lean to Cut Pap Test TAT Pays Off At Baystate Medical

USE OF LEAN METHODS HAS UNLOCKED major improvements at Baystate Health’s Department of Pathology in Springfield, Massachusetts. One Lean project cut average Pap test turnaround time by more than 50%. Another Lean project attacked errors with Advanced Beneficiary Notices (ABN), leading to a 75% reduction in write-offs, worth $1 million!

In the first case, the lab

View Article

No Disruptive Technology In Lab Industry’s Future

CEO SUMMARY: As new diagnostic technologies move through the development pipeline and into widespread clinical use, the scientific knowledge and skill sets needed by laboratory staff and management will change. The emphasis in laboratory medicine will evolve to include more molecular technology, but this evolution will proceed incrementally, giving all laboratories time to adapt.

RAPID ADVANCES

View Article

Are Two Blood Brothers Using Economic Clout?

CEO SUMMARY: Quest Diagnostics Incorporated and Laboratory Corporation of America now dominate the national marketplace for testing referred by physicians’ offices. Release of their second quarter earnings reports provides the first look at their performance following the acquisitions in 2002 which removed American Medical Laboratories, Dynacare, DIANON Systems, and Unilab from the marketplace.

WITH THE RELEASE

View Article